Research progress on the relationship between hypoglycemic drugs and sarcopenia
10.12092/j.issn.1009-2501.2023.01.013
- Author:
Jing CAI
1
;
Binjing PAN
1
;
Jing CAI
2
;
Binjing PAN
2
;
Jingfang LIU
2
Author Information
1. First College of Clinical Medicine, Lanzhou University
2. Department of Endocrinology, First Hospital of Lanzhou University
- Publication Type:Journal Article
- Keywords:
hypoglycemic drugs;
sarcopenia;
type 2 diabetes
- From:
Chinese Journal of Clinical Pharmacology and Therapeutics
2023;28(1):101-108
- CountryChina
- Language:Chinese
-
Abstract:
Sarcopenia is a disease characterized by a decrease in muscle mass and function that can induce adverse events such as falls, weakness, and death. The latest research shows that the use of many hypoglycemic drugs is associated with sarcopenia. Different types of hypoglycemic drugs may have different effects and mechanisms for the quality and function of skeletal muscle. In this paper, we review the research progress of the relationship between hypoglycemic drugs and sarcopenia and the molecular mechanism in recent years to provide a reference for the diagnosis and treatment prevention of sarcopenia in clinical areas.
